ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets
- PMID: 6087354
- PMCID: PMC391607
- DOI: 10.1073/pnas.81.15.4935
ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets
Abstract
Human von Willebrand factor (vWF) and fibrinogen are adhesive plasma glycoproteins essential for formation of a platelet hemostatic plug. We investigated the role of ADP and fibrinogen in binding of vWF to platelets in vitro. Binding of 125I-labeled vWF to human platelets separated from plasma proteins and treated with ADP was specific, and time and concentration dependent, reaching equilibrium at 20 min and approaching saturation at 12 micrograms/ml. The binding was inhibited by EDTA and by prostaglandin I2, a known activator of platelet adenylate cyclase. A purine nucleotide affinity analog, 5'-p-fluorosulfonylbenzoyl adenosine (FSBA), which covalently modifies the ADP binding sites on the human platelet membrane, prevented binding of vWF induced with ADP, as well as with human thrombin and with ionophore A23187, agents known to cause platelet ADP secretion. By comparison, FSBA did not inhibit binding of vWF induced by ristocetin, indicating that the ristocetin mechanism is not dependent on ADP. Human fibrinogen inhibited in a competitive manner the ADP-induced binding of 125I-labeled vWF (9 micrograms/ml) with an IC50 of 25 micrograms/ml. Conversely, unlabeled vWF inhibited ADP-induced binding of 125I-labeled fibrinogen (60 micrograms/ml) with an IC50 of 16 micrograms/ml. A synthetic dodecapeptide (Mr, 1188), analogous with the specific platelet receptor recognition site of human fibrinogen gamma chain (gamma 400-411), inhibited binding of both 125I-labeled vWF and 125I-labeled fibrinogen to ADP-treated platelets, whereas it was without effect on binding of 125I-labeled vWF to ristocetin-treated platelets. These data indicate that vWF and fibrinogen have a common receptor mechanism for their interaction with human platelets that is dependent on ADP occupancy of its binding sites and is recognized by the sequence of 12 amino acid residues at the carboxyl terminus of the human fibrinogen gamma chain.
Similar articles
-
Interaction of von Willebrand factor with human platelets in the plasma milieu.J Clin Invest. 1984 Feb;73(2):421-8. doi: 10.1172/JCI111228. J Clin Invest. 1984. PMID: 6230372 Free PMC article.
-
von Willebrand factor. A protein which binds at the cell surface interface between platelets.J Biol Chem. 1983 Oct 25;258(20):12327-33. J Biol Chem. 1983. PMID: 6605342
-
Inhibition of von Willebrand factor-platelet interaction by fibrinogen.Nature. 1984 Apr 12-18;308(5960):648-9. doi: 10.1038/308648a0. Nature. 1984. PMID: 6324004
-
Characteristics of an ADP receptor mediating platelet activation.Mol Cell Biochem. 1984;59(1-2):101-11. doi: 10.1007/BF00231307. Mol Cell Biochem. 1984. PMID: 6323960 Review.
-
Macromolecules that link platelets following vessel wall injury.Ann N Y Acad Sci. 1987;509:131-41. doi: 10.1111/j.1749-6632.1987.tb30990.x. Ann N Y Acad Sci. 1987. PMID: 2827552 Review.
Cited by
-
Integrin αIIbβ3: from discovery to efficacious therapeutic target.Circ Res. 2013 Apr 12;112(8):1189-200. doi: 10.1161/CIRCRESAHA.112.300570. Circ Res. 2013. PMID: 23580774 Free PMC article. Review.
-
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.J Clin Invest. 1985 Apr;75(4):1198-203. doi: 10.1172/JCI111816. J Clin Invest. 1985. PMID: 3157702 Free PMC article.
-
Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.J Clin Invest. 1985 Nov;76(5):1950-8. doi: 10.1172/JCI112193. J Clin Invest. 1985. PMID: 2414325 Free PMC article.
-
Elucidation of a common structure of selective fibrinogen receptor antagonists.J Comput Aided Mol Des. 1998 Nov;12(6):533-42. doi: 10.1023/a:1008024924329. J Comput Aided Mol Des. 1998. PMID: 9879501
-
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61. doi: 10.1073/pnas.82.23.8057. Proc Natl Acad Sci U S A. 1985. PMID: 3877935 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous